Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Angelucci

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Cancers|July 27, 2022
NF-κB: A Druggable Target in Acute Myeloid LeukemiaBarbara Di Francesco, Daniela Verzella, Daria Capece, et al.
Psychiatry Research|August 2, 2016
Clinical correlates of plasma brain-derived neurotrophic factor in post-traumatic stress disorder spectrum after a natural disasterPaolo Stratta, Patrizia Sanità, Roberto L Bonanni, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 25, 2018
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodelingAndrea Mancini, Alessandro Colapietro, Simona Pompili, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
AuNP Pyrazolo[3,4-<i>d</i>]pyrimidine Nanosystem in Combination with Radiotherapy against GlioblastomaAlessio Molinari, Giulia Iovenitti, Arianna Mancini, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 19, 2018
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ CellsMichela Anna Polidoro, Sandra Rotondi, Roberta Morace, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2018
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatmentAlessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.
Oncotarget|March 13, 2015
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiationNadia Casini, Iris Maria Forte, Gianmarco Mastrogiovanni, et al.
Free Radical Biology & Medicine|November 25, 2017
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation diseaseCinzia Antognelli, Eliana Trapani, Simona Delle Monache, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6Piero Ruscitti, Vasiliki Liakouli, Noemi Panzera, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Cancers|July 27, 2022
NF-κB: A Druggable Target in Acute Myeloid LeukemiaBarbara Di Francesco, Daniela Verzella, Daria Capece, et al.
Psychiatry Research|August 2, 2016
Clinical correlates of plasma brain-derived neurotrophic factor in post-traumatic stress disorder spectrum after a natural disasterPaolo Stratta, Patrizia Sanità, Roberto L Bonanni, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 25, 2018
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodelingAndrea Mancini, Alessandro Colapietro, Simona Pompili, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
AuNP Pyrazolo[3,4-<i>d</i>]pyrimidine Nanosystem in Combination with Radiotherapy against GlioblastomaAlessio Molinari, Giulia Iovenitti, Arianna Mancini, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 19, 2018
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ CellsMichela Anna Polidoro, Sandra Rotondi, Roberta Morace, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2018
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatmentAlessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.
Oncotarget|March 13, 2015
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiationNadia Casini, Iris Maria Forte, Gianmarco Mastrogiovanni, et al.
Free Radical Biology & Medicine|November 25, 2017
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation diseaseCinzia Antognelli, Eliana Trapani, Simona Delle Monache, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6Piero Ruscitti, Vasiliki Liakouli, Noemi Panzera, et al.
Pageof 10